New Delhi, Sept. 3 -- India's pharmaceutical sector continues to show strong export resilience despite facing war-related supply chain shocks, which have become the 'new normal', Pharmexcil chairman Namit Joshi said on Thursday at an event in New Delhi.

Pharmaceutical Export Promotion Council of India (Pharmexcil) operates under the commerce ministry.

Valued at over $50 billion and projected to hit $130 billion by 2030, the pharma market relies heavily on MSMEs to sustain growth, he said.

Despite shipping route closures in the Strait of Hormuz and air-cargo collapses that stranded vaccines and vital raw materials, drug exports expanded 6.8% in the first quarter of fiscal year 2027 (FY27). Industry leaders now treat geopolitical instabi...